AMELIORATIVE EFFECTS OF VITAMINS C AND E ON TENOFOVIR/NEVIRAPINE-INDUCED HEPATORENAL OXIDATIVE STRESS IN ALBINO RATS

AMELIORATIVE EFFECTS OF VITAMINS C AND E ON TENOFOVIR/NEVIRAPINE-INDUCED HEPATORENAL OXIDATIVE STRESS IN ALBINO RATS

Background and Objectives: Oxidative stress has been implicated in xenobiotic-induced hepatorenal toxicity. This research was designed to investigate the effects of vitamins C and E on the baseline and tenofovir/nevirapine-induced liver and kidney levels of superoxide dismutase (SOD), glutathione (G...

Full description

Bibliographic Details
Main Authors:	Elias Adikwu, Williams Apiakise
Format:	Article
Language:	English
Published:	Universitas Gadjah Mada 2016-10-01
Series:	Indonesian Journal of Pharmacy
Subjects:	tenofovir nevirapine liver kidney oxidative stress antioxidants
Online Access:	http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1096

Similar Items

Possible hepatotoxic consequence of nevirapine use in juvenile albino rats
by: Elias Adikwu, et al.
Published: (2017-08-01)

Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-Trial)
by: Weberschock T, et al.
Published: (2009-12-01)

Effect of tenofovir Administration And Withdrawl On The Kidney Tissues Of Adult Male Albino Rats And The Protective Role Of Vitamin E
by: Rasha M. Abd El-Fattah, et al.
Published: (2019-07-01)

Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
by: Prabhakar Panzade, et al.
Published: (2021-09-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine
by: Ashley R. Longstreet, et al.
Published: (2013-11-01)

Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan
by: Chun-Yuan Lee, et al.
Published: (2017-04-01)

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital
by: William Kondo, et al.

Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS
by: Anggriani Yusi, et al.
Published: (2019-08-01)

Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India
by: Mini S Jacob, et al.
Published: (2011-01-01)

Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV
by: Jared M. Gilbert, et al.
Published: (2022-11-01)

Possible ameliorative effects of hydromethanol extract of Thymus vulgaris on cadmium induced hepatorenal toxicity in rats
by: Remigius I. ONOJA, et al.
Published: (2020-09-01)

Green HPLC quantification method of lamivudine, zidovudine and nevirapine with identification of related substances in tablets
by: Ludivine Vieira-Sellaï, et al.
Published: (2022-07-01)

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
by: Andrea Giacomelli, et al.
Published: (2018-11-01)

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up
by: Juan Tiraboschi, et al.
Published: (2019-11-01)

Combined antiretroviral therapy with nevirapine of HIV-infected adults
by: A V Kravchenko
Published: (2004-11-01)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
by: Hung-Yao Lin, et al.
Published: (2022-04-01)

The Role of Drug Transporters in the Kidney: Lessons from Tenofovir
by: Darren Michael Moss, et al.
Published: (2014-11-01)

Studies on some neuropharmacological properties of Nevirapine in mice
by: Peter Uchogu Ahmadu, et al.
Published: (2022-06-01)

Oxidation of 2-Hydroxynevirapine, a Phenolic Metabolite of the Anti-HIV Drug Nevirapine: Evidence for an Unusual Pyridine Ring Contraction
by: Frederick A. Beland, et al.
Published: (2012-03-01)

Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
by: Julia Notter, et al.
Published: (2019-04-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01)

Melatonin and N- Acetylcysteine as Remedies for Tramadol-Induced Hepatotoxicity in Albino Rats
by: Elias Adikwu, et al.
Published: (2017-09-01)

Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B
by: Juan Li, et al.
Published: (2021-06-01)

Corrigendum: The role of drug transporters in the kidney: lessons from tenofovir
by: Darren eMoss
Published: (2015-02-01)

Potential therapeutic effect of Moroccan propolis in hyperglycemia, dyslipidemia, and hepatorenal dysfunction in diabetic rats
by: Nawal El Menyiy, et al.
Published: (2019-11-01)

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
by: Giacomo Stroffolini, et al.
Published: (2024-02-01)

The protective effect of propolis against aluminum chloride-induced hepatorenal toxicity in albino rats
by: Hanan A. Okail, et al.
Published: (2020-06-01)

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
by: M. Matilde Marques, et al.
Published: (2013-04-01)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
by: Mariana Moura Nascimento, et al.
Published: (2022-08-01)

Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient
by: Leelavathy Budamakuntla, et al.
Published: (2014-01-01)

Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
by: Hongxia Shang, et al.
Published: (2019-12-01)

Comparative protective assessments of some antioxidants against cyclophosphamide-induced kidney toxicity in albino rats
by: Elias Adikwu, et al.
Published: (2019-05-01)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021-08-01)

Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa
by: Jacques D. du Toit, et al.
Published: (2021-02-01)

Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting
by: Faithful Makita-Chingombe, et al.
Published: (2019-05-01)

Coenzyme Q 10 Abrogates Flutamide-induced Hepatotoxicity in Albino Rats
by: Elias Adikwu, et al.
Published: (2019-10-01)

Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV
by: Nicole Marie Lioufas, et al.
Published: (2018-06-01)

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
by: Pei-Yuan Su, et al.
Published: (2021-11-01)